Treatment Approach for Median Arcuate Ligament Syndrome (MALS)
Surgical release of the median arcuate ligament is the first-line treatment for MALS, providing symptomatic relief in 84.6% of patients, with better outcomes in patients who have postprandial pain patterns, age between 40-60 years, and significant weight loss. 1
Diagnostic Confirmation Before Treatment
Before initiating treatment, proper diagnosis is essential:
CT angiography (CTA) is the first-line imaging modality (95-100% sensitivity and specificity)
Mesenteric angiography for confirmation
Duplex Doppler ultrasound as a screening tool
- Peak systolic velocity cutoffs: SMA (295 cm/s for 50% stenosis) and celiac artery (240 cm/s for 70% stenosis) 1
Treatment Algorithm
First-Line Treatment: Surgical Release
Laparoscopic or open surgical release of the median arcuate ligament
Celiac ganglionectomy should be performed concurrently with ligament release
Second-Line Treatment: Vascular Intervention
For patients with persistent symptoms after surgical release and residual celiac artery stenosis >30%:
Endovascular intervention with celiac artery stenting
Vascular reconstruction may be necessary in cases where stenting is not feasible or unsuccessful 4
Follow-up Protocol
- Clinical evaluation at 1,3,6, and 12 months after intervention 1
- Imaging follow-up:
Predictors of Treatment Success
- Postprandial pain pattern
- Age between 40-60 years
- Weight loss of 20 pounds or more 1
- Absence of cardiovascular risk factors 3
Important Considerations and Pitfalls
Diagnostic pitfall: Celiac axis narrowing occurs in approximately 20% of the general population, often asymptomatic due to collateral circulation 1
Treatment pitfall: High rate of open conversion (9.1%) with laparoscopic approach, though no perioperative deaths have been reported 2
Diagnostic confirmation: In patients with atypical presentations, consider diagnostic celiac plexus block using local anesthetic before surgery - patients who experience relief from the block are more likely to benefit from surgical intervention 3
Pathophysiology consideration: Evidence suggests MALS may be primarily a neurogenic disorder rather than a vascular disease, explaining why some patients with residual stenosis or even occlusion after surgery still experience symptom relief 3
Long-term monitoring: Patients require surveillance for potential complications including aneurysm formation or restenosis 5